Page last updated: 2024-08-24

telmisartan and omega-n-methylarginine

telmisartan has been researched along with omega-n-methylarginine in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bellien, J; Bourkaib, R; Eltchaninoff, H; Iacob, M; Joannides, R; Thuillez, C1
Brillante, DG; Brillante, RE; Howes, LG; O'Sullivan, AJ1
Barini, A; Cardillo, C; Di Daniele, N; Mores, N; Schinzari, F; Tesauro, M; Veneziani, A1

Trials

2 trial(s) available for telmisartan and omega-n-methylarginine

ArticleYear
AT1 receptor blockade prevents the decrease in conduit artery flow-mediated dilatation during NOS inhibition in humans.
    Clinical science (London, England : 1979), 2007, Volume: 112, Issue:7

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents, Non-Steroidal; Area Under Curve; Aspirin; Benzimidazoles; Benzoates; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Endothelium, Vascular; Fluconazole; Humans; Male; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Radial Artery; Regional Blood Flow; Telmisartan; Vascular Resistance; Vasodilation; Vasodilator Agents

2007
Effects of cardiovascular angiotensin II type 1 receptor blockade on nitric oxide synthase inhibition in patients with insulin resistance syndrome.
    Blood pressure, 2009, Volume: 18, Issue:3

    Topics: Adult; Angiotensin II; Arteries; Benzimidazoles; Benzoates; Blood Pressure; Cardiovascular System; Cross-Over Studies; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Hemodynamics; Humans; Insulin Resistance; Male; Metabolic Syndrome; Nitric Oxide Synthase; omega-N-Methylarginine; Photoplethysmography; Receptor, Angiotensin, Type 1; Telmisartan; Vascular Resistance

2009

Other Studies

1 other study(ies) available for telmisartan and omega-n-methylarginine

ArticleYear
Beneficial Effects of Apelin on Vascular Function in Patients With Central Obesity.
    Hypertension (Dallas, Tex. : 1979), 2017, Volume: 69, Issue:5

    Topics: Acetylcholine; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Annexins; Apelin; Benzimidazoles; Benzoates; Endothelium, Vascular; Female; Forearm; Humans; Imidazoles; Intercellular Signaling Peptides and Proteins; Male; Middle Aged; Nitric Oxide; Nitroprusside; Obesity; omega-N-Methylarginine; Pyridines; Regional Blood Flow; Telmisartan; Vasodilation

2017